The psychosocial burden of chronic hand eczema: reflections on its assessment and methodological limitations

Journal of Dermatological Treatment · Published 2026-08-03 · DOI 10.1080/09546634.2026.2709915

Free full text

Authors (1)

Angelo Franz Lopez Agrada

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Citation

Agrada, A. (2026). The psychosocial burden of chronic hand eczema: reflections on its assessment and methodological limitations. Journal of Dermatological Treatment. https://doi.org/10.1080/09546634.2026.2709915

Related articles

• Health-related quality of life in individuals with Chronic hand eczema – Findings from the multinational CHECK study · Journal of Dermatological Treatment · 2026 · Cites or is cited by this article · Same journal
• Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years · Journal of Dermatological Treatment · 2026 · Same journal
• Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial · Journal of Dermatological Treatment · 2026 · Same journal
• Early response to ivarmacitinib and its impact on long-term efficacy in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of a phase-III trial · Journal of Dermatological Treatment · 2026 · Same journal
• Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort study · Journal of Dermatological Treatment · 2026 · Same journal
• Effect of methotrexate on endothelial function in psoriasis patients · Journal of Dermatological Treatment · 2026 · Same journal
• Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis · Journal of Dermatological Treatment · 2026 · Same journal
• Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical trials · Journal of Dermatological Treatment · 2026 · Same journal
• Distinct ocular safety profiles of dupilumab and upadacitinib in atopic dermatitis: a real-world study with ophthalmological and microbiological assessment · Journal of Dermatological Treatment · 2026 · Same journal
• Recalcitrant tinea infections due to Trichophyton indotineae in the United States (2025–2026): a retrospective case series identified by real-time PCR · Journal of Dermatological Treatment · 2026 · Same journal